Correlations Between Acute Coronary Syndrome and Novel Inflammatory Markers (Systemic Immune-Inflammation Index, Systemic Inflammation Response Index, and Aggregate Index of Systemic Inflammation) in Patients with and without Diabetes or Prediabetes

References

• Magliano D, Boyko EJ. IDF Diabetes Atlas. 10th ed. Brussels: International Diabetes Federation; 2021.
   Google Scholar
• Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017. Cardiovasc Diabetol. 2018;17(1):83. doi:10.1186/s12933-018-0728-6
   PubMed Web of Science ®Google Scholar
• Poznyak A, Grechko AV, Poggio P, Myasoedova VA, Alfieri V, Orekhov AN. The diabetes mellitus-atherosclerosis connection: the role of lipid and glucose metabolism and chronic inflammation. Int J Mol Sci. 2020;21(5). doi:10.3390/ijms21051835
   Web of Science ®Google Scholar
• Babes EE, Bustea C, Behl T, et al. Acute coronary syndromes in diabetic patients, outcome, revascularization, and antithrombotic therapy. Biomed Pharmacother. 2022;148:112772. doi:10.1016/j.biopha.2022.112772
   PubMed Web of Science ®Google Scholar
• Liu Y, Ye T, Chen L, et al. Systemic immune-inflammation index predicts the severity of coronary stenosis in patients with coronary heart disease. Coron Artery Dis. 2021;32(8):715–720. doi:10.1097/MCA.0000000000001037
   PubMed Web of Science ®Google Scholar
• Dziedzic EA, Gąsior JS, Tuzimek A, et al. Investigation of the associations of novel inflammatory biomarkers-systemic inflammatory index (SII) and systemic inflammatory response index (SIRI)-with the severity of coronary artery disease and acute coronary syndrome occurrence. Int J Mol Sci. 2022;23(17). doi:10.3390/ijms23179553
   Web of Science ®Google Scholar
• Dziedzic EA, Gąsior JS, Tuzimek A, Kochman W. Blood count-derived inflammatory markers and acute complications of ischemic heart disease in elderly women. J Clin Med. 2023;12(4). doi:10.3390/jcm12041369
   Web of Science ®Google Scholar
• Xia Y, Xia C, Wu L, Li Z, Li H, Zhang J. Systemic Immune Inflammation Index (SII), System Inflammation Response Index (SIRI) and risk of all-cause mortality and cardiovascular mortality: a 20-year follow-up cohort study of 42,875 US Adults. J Clin Med. 2023;12(3). doi:10.3390/jcm12031128
   Web of Science ®Google Scholar
• Su G, Zhang Y, Xiao R, Zhang T, Gong B. Systemic immune-inflammation index as a promising predictor of mortality in patients with acute coronary syndrome: a real-world study. J Int Med Res. 2021;49(5):3000605211016274. doi:10.1177/03000605211016274
   Web of Science ®Google Scholar
• Xu X, Xie Y, Gu X, et al. Association between systemic immune inflammation level and poor prognosis across different glucose metabolism status in coronary artery disease patients. J Inflamm Res. 2023;16:4031–4042. doi:10.2147/JIR.S425189
   PubMed Web of Science ®Google Scholar
• Fan W, Zhang Y, Gao X, et al. The prognostic value of a derived neutrophil-lymphocyte ratio in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Clin Appl Thromb Hemost. 2021;27:10760296211034579. doi:10.1177/10760296211034579
   Web of Science ®Google Scholar
• Hayıroğlu Mİ, Çınar T, Çinier G, et al. Evaluating systemic immune-inflammation index in patients with implantable cardioverter defibrillator for heart failure with reduced ejection fraction. Pacing Clin Electrophysiol. 2022;45(2):188–195. doi:10.1111/pace.14436
   PubMed Web of Science ®Google Scholar
• Yang Y-L, Wu C-H, Hsu P-F, et al. Systemic immune-inflammation index (SII) predicted clinical outcome in patients with coronary artery disease. Eur J Clin Invest. 2020;50(5):e13230. doi:10.1111/eci.13230
   PubMed Web of Science ®Google Scholar
• Saylik F, Akbulut T. Systemic immune-inflammation index predicts major cardiovascular adverse events in patients with st-segment elevated myocardial infarction. Arq Bras Cardiol. 2022;119(1):14–22. doi:10.36660/abc.20210412
   PubMed Web of Science ®Google Scholar
• Li Q, Ma X, Shao Q, et al. Prognostic impact of multiple lymphocyte-based inflammatory indices in acute coronary syndrome patients. Front Cardiovasc Med. 2022;9:811790. doi:10.3389/fcvm.2022.811790
   PubMed Web of Science ®Google Scholar
• Han K, Shi D, Yang L, et al. Prognostic value of systemic inflammatory response index in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Ann Med. 2022;54(1):1667–1677. doi:10.1080/07853890.2022.2083671
   PubMed Web of Science ®Google Scholar
• Fan W, Wei C, Liu Y, et al. the prognostic value of hematologic inflammatory markers in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Clin Appl Thromb Hemost. 2022;28:10760296221146183. doi:10.1177/10760296221146183
   Web of Science ®Google Scholar
• Laichuthai N, Abdul-Ghani M, Kosiborod M, Parksook WW, Kerr SJ, DeFronzo RA. Newly discovered abnormal glucose tolerance in patients with acute myocardial infarction and cardiovascular outcomes: a meta-analysis. Diabetes Care. 2020;43(8):1958–1966. doi:10.2337/dc20-0059
   PubMed Web of Science ®Google Scholar
• IARC. Handbooks on Cancer Prevention, Tobacco Control, Methods for Evaluating Tobacco Control Policies (Lyon, France) 12 ; 2008.
   Google Scholar
• Cosentino F, Grant PJ, Aboyans V, et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2020;41(2):255–323. doi:10.1093/eurheartj/ehz486
   PubMed Web of Science ®Google Scholar
• Unger T, Borghi C, Charchar F, et al. International society of hypertension global hypertension practice guidelines. Hypertension. 2020;75(6):1334–1357. doi:10.1161/HYPERTENSIONAHA.120.15026
   PubMed Web of Science ®Google Scholar
• Mach F, Baigent C, Catapano AL, et al. ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111–188. doi:10.1093/eurheartj/ehz455
   PubMed Web of Science ®Google Scholar
• Lawton JS, Tamis-Holland JE, Bangalore S, et al. ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology/American heart association joint committee on clinical practice guidelines. Circulation. 2022;145(3):e18–e114. doi:10.1161/CIR.0000000000001038
   PubMed Web of Science ®Google Scholar
• Collet J-P, Thiele H, Barbato E, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42(14):1289–1367. doi:10.1093/eurheartj/ehaa575
   PubMed Web of Science ®Google Scholar
• Dolu AK, Karayiğit O, Ozkan C, Çelik MC, Kalçık M. Relationship between intracoronary thrombus burden and systemic immune-inflammation index in patients with ST-segment elevation myocardial infarction. Acta Cardiol. 2023;78(1):72–79. doi:10.1080/00015385.2022.2035082
   PubMed Web of Science ®Google Scholar
• Özkan U, Gürdoğan M, Öztürk C, et al. Systemic immune-inflammation index: a novel predictor of coronary thrombus burden in patients with non-ST acute coronary syndrome. Medicina. 2022;58(2). doi:10.3390/medicina58020143
   Google Scholar
• Çelik MC, Karayiğit O, Ozkan C, Dolu AK, Kalçık M. Relationship between systemic inflammation index and no-reflow phenomenon in patients with ST-segment elevation myocardial infarction. Angiology. 2023;74(4):387–394. doi:10.1177/00033197221115562
   PubMed Web of Science ®Google Scholar
• Esenboğa K, Kurtul A, Yamantürk YY, Tan TS, Tutar DE. Systemic immune-inflammation index predicts no-reflow phenomenon after primary percutaneous coronary intervention. Acta Cardiol. 2022;77(1):59–65. doi:10.1080/00015385.2021.1884786
   PubMed Web of Science ®Google Scholar
• Wang P, Guo X, Zhou Y, et al. Monocyte-to-high-density lipoprotein ratio and systemic inflammation response index are associated with the risk of metabolic disorders and cardiovascular diseases in general rural population. Front Endocrinol. 2022;13:944991. doi:10.3389/fendo.2022.944991
   PubMed Web of Science ®Google Scholar
• B ÇT, Ahbab S, Türker F, et al. Systemic immune-inflammation and systemic inflammation response indices are predictive markers of mortality in inpatients internal medicine services. Int J Gen Med. 2023;16:3163–3170. doi:10.2147/IJGM.S420332
   PubMed Web of Science ®Google Scholar
• Urbanowicz T, Michalak M, Olasińska-Wiśniewska A, et al. Neutrophil counts, neutrophil-to-lymphocyte ratio, and systemic inflammatory response index (SIRI) predict mortality after off-pump coronary artery bypass surgery. Cells. 2022;11(7). doi:10.3390/cells11071124
   PubMed Web of Science ®Google Scholar
• Murat B, Murat S, Ozgeyik M, Bilgin M. Comparison of pan-immune-inflammation value with other inflammation markers of long-term survival after ST-segment elevation myocardial infarction. Eur J Clin Invest. 2023;53(1):e13872. doi:10.1111/eci.13872
   PubMed Web of Science ®Google Scholar
• Mangalesh S, Dudani S, Mahesh NK. Development of a novel inflammatory index to predict coronary artery disease severity in patients with acute coronary syndrome. Angiology. 2023;33197231151564. doi:10.1177/00033197231151564
   PubMed Web of Science ®Google Scholar
• Magoon R, Kashav RC, Shri I, Dey S, Walian A, Kohli JK. VASOplegia is Predicted by Preoperative Platelet-LEucocyte conGlomerate Indices in Cardiac Surgery (VASOPLEGICS): a retrospective single-center study. Ann Card Anaesth. 2022;25(4):414–421. doi:10.4103/aca.aca_54_21
   PubMed Web of Science ®Google Scholar
• Chen Y, Xie K, Han Y, Xu Q, Zhao X. An easy-to-use nomogram based on sii and siri to predict in-hospital mortality risk in elderly patients with acute myocardial infarction. J Inflamm Res. 2023;16:4061–4071. doi:10.2147/JIR.S427149
   PubMed Web of Science ®Google Scholar
• Ozkan E, Erdogan A, Karagoz A, Tanboğa IH. Comparison of systemic immune-inflammation index and Naples prognostic score for prediction coronary artery severity patients undergoing coronary computed tomographic angiography. Angiology. 2023;33197231170979. doi:10.1177/00033197231170979
   Web of Science ®Google Scholar
• Xia T-L, Li Y-M, Huang F-Y, et al. The triglyceride paradox in the mortality of coronary artery disease. Lipids Health Dis. 2019;18(1):21. doi:10.1186/s12944-019-0972-0
   PubMedGoogle Scholar
• Dong J, Yang S, Zhuang Q, et al. The associations of lipid profiles with cardiovascular diseases and death in a 10-year prospective cohort study. Front Cardiovasc Med. 2021;8:745539. doi:10.3389/fcvm.2021.745539
   PubMed Web of Science ®Google Scholar
• Cheng Y-T, Liu T-J, Lai H-C, et al. Lower serum triglyceride level is a risk factor for in-hospital and late major adverse events in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention- a cohort study. BMC Cardiovasc Disord. 2014;14:143. doi:10.1186/1471-2261-14-143
   PubMed Web of Science ®Google Scholar
• Hirata A, Okamura T, Hirata T, et al. Relationship between non-fasting triglycerides and cardiovascular disease mortality in a 20-year follow-up study of a Japanese general population: NIPPON DATA90. J Epidemiol. 2022;32(7):303–313. doi:10.2188/jea.JE20200399
   PubMed Web of Science ®Google Scholar
• Hayıroğlu Mİ, Çınar T, Çiçek V, Palice A, Ayhan G, Tekkeşin Aİ. The triglyceride-glucose index can predict long-term major adverse cardiovascular events in Turkish patients with high cardiovascular risk. J Lipid Atheroscler. 2022;11(3):280–287. doi:10.12997/jla.2022.11.3.280
   PubMedGoogle Scholar
• Özcan KS, Hayıroğlu MI, Çınar T. Admission triglyceride-glucose index is predictor of long-term mortality and appropriate implantable cardiac defibrillator therapy in patients with heart failure. Biomarker Med. 2023;17(10):487–496. doi:10.2217/bmm-2023-0113
   PubMed Web of Science ®Google Scholar
• Hayıroğlu Mİ, Altay S. The role of artificial intelligence in coronary artery disease and atrial fibrillation. Balkan Med J. 2023;40(3):151–152. doi:10.4274/balkanmedj.galenos.2023.06042023
   PubMed Web of Science ®Google Scholar